New drugs against COVID-19 and Ivermectin
Some believe that the new drugs brought onto the market are the same as Ivermectin. See some fact checks at the following pages: Reuters
Coronavirus: What does blood type have to do with COVID-19?
COVID-19 can take mild to severe courses: Sometimes there are no symptoms, and sometimes people die. New research suggests that blood types could play a rather important role by affecting the immune response. German and Norwegian researchers have analyzed the different blood types with regards to COVID-19. They have come up with some amazing results,
Dexamethasone proves first life-saving drug
A cheap and widely available drug can help save the lives of patients seriously ill with coronavirus. The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say. The drug is part of the world's biggest trial testing existing treatments to see if they also work for
WHO halts trials of hydroxychloroquine / Dutch workers on mink farms could be first humans infected by animals
Read full article on The Straits Times GENEVA • The World Health Organisation (WHO) has suspended the testing of the malaria drug hydroxychloroquine in Covid-19 patients because of safety concerns, according to its director-general Tedros Adhanom Ghebreyesus. Hydroxycholoroquine has been touted by US President Donald Trump and others as a possible treatment for the disease
A human monoclonal antibody blocking SARS-CoV-2 infection
This cross-neutralizing antibody targets a communal epitope on the coronaviruses and may offer potential for prevention and treatment of COVID-19. See more artricles on different sites such as Nature.com | Bloomberg | University of Oxford
NIH Panel Recommends Against Drug Combination Trump Has Promoted For COVID-19
Read full article on NPR A panel of experts convened by the National Institute of Allergy and Infectious Diseases recommends against doctors using a combination of hydroxychloroquine and azithromycin for the treatment of COVID-19 patients because of potential toxicities. "The combination of hydroxychloroquine and azithromycin was associated with QTc prolongation in patients with COVID-19," the